相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
Rebecca Roylance et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer
Anthoula Koliadi et al.
ACTA ONCOLOGICA (2010)
High cyclin B1 expression is associated with poor survival in breast cancer
K. Aaltonen et al.
BRITISH JOURNAL OF CANCER (2009)
Aurora-A interacts with Cyclin B1 and enhances its stability
Lih Qina et al.
CANCER LETTERS (2009)
Survivin: A new target for anti-cancer therapy
Brid M. Ryan et al.
CANCER TREATMENT REVIEWS (2009)
Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
Roshan Agarwal et al.
CLINICAL CANCER RESEARCH (2009)
In vitro and in vivo analysis of B-Myb in basal-like breast cancer
A. R. Thorner et al.
ONCOGENE (2009)
Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
R. Stuart-Harris et al.
BREAST (2008)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
Expression of Aurora a (but not Aurora B) is predictive of survival in breast cancer
Yasmine Nadler et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer
A. Neri et al.
EJSO (2008)
Estrogen and MYB in breast cancer:: potential for new therapies
Thomas J. Gonda et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
B-MYB Is Essential for Normal Cell Cycle Progression and Chromosomal Stability of Embryonic Stem Cells
Kirill V. Tarasov et al.
PLOS ONE (2008)
Ki67 and cyclin A as prognostic factors in early breast cancer.: What are the optimal cut-off values?
C. Ahlin et al.
HISTOPATHOLOGY (2007)
Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis
R. Rahmanzadeh et al.
CELL PROLIFERATION (2007)
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E. de Azambuja et al.
BRITISH JOURNAL OF CANCER (2007)
Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics
Guillermo Carreno et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Roles of aurora kinases in mitosis and tumorigenesis
Jingyan Fu et al.
MOLECULAR CANCER RESEARCH (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tissue microarrays for comparing molecular features with proliferation activity in breast cancer
C Ruiz et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1
BM Ryan et al.
ANNALS OF ONCOLOGY (2006)
Survivin modulates microtubule dynamics and nucleation throughout the cell cycle
J Rosa et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells
J Bullwinkel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer
A Sala
EUROPEAN JOURNAL OF CANCER (2005)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
M Colozza et al.
ANNALS OF ONCOLOGY (2005)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Proliferation marker Ki-67 in early breast cancer
A Urruticoechea et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Nuclear or cytoplasmic expression of survivin: What is the significance?
FZ Li et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families
H Eerola et al.
BREAST CANCER RESEARCH (2005)
Improved grading of breast adenocarcinomas based on genomic instability
U Kronenwett et al.
CANCER RESEARCH (2004)
STK15/aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis
ME Royce et al.
CANCER (2004)
BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition
M Ouchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prognostic importance of survivin in breast cancer
SM Kennedy et al.
BRITISH JOURNAL OF CANCER (2003)
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer
H Kühling et al.
JOURNAL OF PATHOLOGY (2003)
Ki-67 expression in breast carcinoma - Its association with grading systems, clinical parameters, and other prognostic factors - A surrogate marker?
H Trihia et al.
CANCER (2003)
Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas
X Mao et al.
BLOOD (2003)
Correlation between MIB-1 and other proliferation markers -: Clinical implications of the MIB-1 cutoff value
F Spyratos et al.
CANCER (2002)
Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells
P Meraldi et al.
EMBO JOURNAL (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Subcellular localisation of cyclin B, Cdc2 and p21WAF1/CIP1 in breast cancer:: association with prognosis
ZE Winters et al.
EUROPEAN JOURNAL OF CANCER (2001)
Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers
Y Miyoshi et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients
E Okada et al.
CANCER LETTERS (2001)
分享论文
